Capital Fund Management S.A. Has $3.07 Million Holdings in The Chemours Company (NYSE:CC)

Capital Fund Management S.A. boosted its position in shares of The Chemours Company (NYSE:CC - Free Report) by 14.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 181,579 shares of the specialty chemicals company's stock after purchasing an additional 22,901 shares during the period. Capital Fund Management S.A. owned 0.12% of Chemours worth $3,069,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Chemours during the 4th quarter worth about $30,702,000. Bank of Montreal Can raised its position in Chemours by 1,496.4% during the fourth quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock valued at $16,110,000 after acquiring an additional 893,530 shares in the last quarter. Invesco Ltd. grew its position in Chemours by 141.5% in the fourth quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company's stock worth $17,238,000 after acquiring an additional 597,638 shares in the last quarter. Peregrine Capital Management LLC acquired a new position in shares of Chemours during the 4th quarter worth $5,731,000. Finally, Channing Capital Management LLC bought a new position in shares of Chemours during the 4th quarter valued at $4,701,000. Institutional investors and hedge funds own 76.26% of the company's stock.

Chemours Stock Performance

Shares of Chemours stock traded up $0.35 during midday trading on Friday, hitting $11.37. The company had a trading volume of 1,640,388 shares, compared to its average volume of 1,838,233. The stock has a market cap of $1.70 billion, a PE ratio of 19.94 and a beta of 1.84. The Chemours Company has a 1-year low of $9.33 and a 1-year high of $29.21. The business's 50 day simple moving average is $13.83 and its two-hundred day simple moving average is $17.31. The company has a debt-to-equity ratio of 6.70, a current ratio of 1.68 and a quick ratio of 0.92.

Chemours (NYSE:CC - Get Free Report) last released its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share for the quarter, beating the consensus estimate of $0.10 by $0.01. Chemours had a net margin of 1.51% and a return on equity of 26.54%. The business had revenue of $1.36 billion during the quarter, compared to analysts' expectations of $1.37 billion. As a group, equities analysts predict that The Chemours Company will post 2.03 EPS for the current fiscal year.

Chemours Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were given a $0.25 dividend. The ex-dividend date was Friday, February 28th. This represents a $1.00 annualized dividend and a yield of 8.80%. Chemours's dividend payout ratio (DPR) is currently 175.44%.

Analyst Upgrades and Downgrades

Several research firms have commented on CC. Mizuho set a $15.00 target price on shares of Chemours in a research report on Tuesday. Morgan Stanley lowered their price objective on Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a report on Monday, January 13th. Truist Financial reduced their target price on Chemours from $27.00 to $22.00 and set a "buy" rating for the company in a report on Monday, April 14th. BMO Capital Markets lowered their price target on Chemours from $34.00 to $27.00 and set an "outperform" rating on the stock in a report on Wednesday, February 19th. Finally, The Goldman Sachs Group reduced their price objective on shares of Chemours from $24.00 to $21.00 and set a "neutral" rating for the company in a research note on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $21.56.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.